These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 37633929)

  • 1. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories.
    Birhanu AG
    Clin Proteomics; 2023 Aug; 20(1):32. PubMed ID: 37633929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of clinical mass spectrometry in pathology.
    Fung AWS; Sugumar V; Ren AH; Kulasingam V
    J Clin Pathol; 2020 Feb; 73(2):61-69. PubMed ID: 31690564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empowering Clinical Diagnostics with Mass Spectrometry.
    Banerjee S
    ACS Omega; 2020 Feb; 5(5):2041-2048. PubMed ID: 32064364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE; Lane L
    Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers.
    Wenk D; Zuo C; Kislinger T; Sepiashvili L
    Clin Proteomics; 2024 Jan; 21(1):6. PubMed ID: 38287260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of MALDI-TOF mass spectrometry in clinical proteomics.
    Greco V; Piras C; Pieroni L; Ronci M; Putignani L; Roncada P; Urbani A
    Expert Rev Proteomics; 2018 Aug; 15(8):683-696. PubMed ID: 30058389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of metabolomics and proteomics based on capillary electrophoresis-mass spectrometry].
    Wang F; Wang S; Cong H; Yu B
    Se Pu; 2020 Sep; 38(9):1013-1021. PubMed ID: 34213267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?
    Lehmann S; Brede C; Lescuyer P; Cocho JA; Vialaret J; Bros P; Delatour V; Hirtz C;
    Clin Chim Acta; 2017 Apr; 467():51-58. PubMed ID: 27265523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry for translational proteomics: progress and clinical implications.
    Baker ES; Liu T; Petyuk VA; Burnum-Johnson KE; Ibrahim YM; Anderson GA; Smith RD
    Genome Med; 2012; 4(8):63. PubMed ID: 22943415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry applied to diagnosis, prognosis, and therapeutic targets identification for the novel coronavirus SARS-CoV-2: A review.
    Lima NM; Fernandes BLM; Alves GF; de Souza JCQ; Siqueira MM; Patrícia do Nascimento M; Moreira OBO; Sussulini A; de Oliveira MAL
    Anal Chim Acta; 2022 Feb; 1195():339385. PubMed ID: 35090661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum proteomics using mass spectrometry.
    Hood BL; Malehorn DE; Conrads TP; Bigbee WL
    Methods Mol Biol; 2009; 520():107-28. PubMed ID: 19381950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.
    Lin SY; Hsu WH; Lin CC; Chen CJ
    Biomedicine (Taipei); 2014; 4(4):25. PubMed ID: 25520938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.
    Macklin A; Khan S; Kislinger T
    Clin Proteomics; 2020; 17():17. PubMed ID: 32489335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
    Zhao YY; Lin RC
    Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.